Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:50 pm Purchase |
2021-12-31 | 13G | BridgeBio Pharma, Inc. BBIO |
Kumar Neil | 9,003,211 6.050% |
672,614 (+8.07%) |
Filing History |
| 2022-02-09 3:33 pm Purchase |
2021-12-31 | 13G | BridgeBio Pharma, Inc. BBIO |
The Vanguard Group | 9,331,683 6.340% |
2,890,371 (+44.87%) |
Filing History |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | BridgeBio Pharma, Inc. BBIO |
BLACKROCK INC BLK |
9,275,590 6.300% |
2,758,046 (+42.32%) |
Filing History |
| 2021-02-17 5:28 pm Sale |
2020-02-11 | 13D | BridgeBio Pharma, Inc. BBIO |
KKR Genetic Disorder L.P. | 31,060,971 20.900% |
-3,450,000 (-10.00%) |
Filing History |
| 2021-02-16 5:02 pm Sale |
2020-12-31 | 13G | BridgeBio Pharma, Inc. BBIO |
Kumar Neil | 8,330,597 6.740% |
-288,186 (-3.34%) |
Filing History |
| 2021-02-16 3:36 pm Unchanged |
2020-12-31 | 13G | BridgeBio Pharma, Inc. BBIO |
PERCEPTIVE ADVISORS LLC | 6,706,268 5.500% |
0 (Unchanged) |
Filing History |
| 2021-02-12 7:33 pm Sale |
2020-12-31 | 13G | BridgeBio Pharma, Inc. BBIO |
AMERICAN INTERNATIONAL GROUP INC AIG |
3,381,412 2.800% |
-3,383,180 (-50.01%) |
Filing History |
| 2021-02-10 10:39 am Purchase |
2020-12-31 | 13G | BridgeBio Pharma, Inc. BBIO |
The Vanguard Group | 6,441,312 5.250% |
6,441,312 (New Position) |
Filing History |
| 2021-02-05 07:51 am Purchase |
2020-12-31 | 13G | BridgeBio Pharma, Inc. BBIO |
BLACKROCK INC BLK |
6,517,544 5.300% |
6,517,544 (New Position) |
Filing History |
| 2021-01-26 4:23 pm Sale |
2021-01-26 | 13D | BridgeBio Pharma, Inc. BBIO |
Eidos Therapeutics Inc. EIDX |
0 0.000% |
-44,651,896 (Position Closed) |
Filing History |
| 2021-01-26 09:00 am Sale |
2021-01-26 | 13D | EIDOS THERAPEUTICS INC EIDX |
BridgeBio Pharma Inc. BBIO |
1,000 100.000% |
-24,574,501 (-100.00%) |
Filing History |
| 2020-10-15 4:17 pm Purchase |
2020-10-05 | 13D | BridgeBio Pharma, Inc. BBIO |
Eidos Therapeutics Inc. EIDX |
44,651,896 36.400% |
44,651,896 (New Position) |
Filing History |
| 2020-10-06 4:45 pm Unchanged |
2020-10-05 | 13D | BridgeBio Pharma, Inc. BBIO |
KKR Genetic Disorder L.P. | 34,510,971 28.200% |
0 (Unchanged) |
Filing History |
| 2020-10-05 5:30 pm Unchanged |
2020-10-05 | 13D | EIDOS THERAPEUTICS INC EIDX |
BridgeBio Pharma Inc. BBIO |
24,575,501 63.700% |
0 (Unchanged) |
Filing History |
| 2020-06-01 5:09 pm Sale |
2020-05-28 | 13D | BridgeBio Pharma, Inc. BBIO |
KKR Genetic Disorder L.P. | 34,510,971 28.400% |
-2,389,690 (-6.48%) |
Filing History |